FDA expands tirzepatide indication to cardiovascular risk reduction

• by Kathryn Wighton

• August 28, 2026

Gastrointestinal Bleeding Risk Associated With Pulse Pressure in Patients With Atrial Fibrillation: Retrospective Cohort Study

• by Michel Abou Khalil, Carlo El Khoury, Yishi Jia, Maximilian Moersdorf, Christian Massad, Alex El Darzi, Yara Menassa, Mohammad Montaser Atasi, Ghassan Bidaoui, Hadi Younes, Ala Assaf, Mario Mekhael, Eli Tsakiris, Chanho Lim, Charbel Noujaim, Abboud Hassan, Yingshuo Liu, Mary Margot M Maleckar, Rodolfo A Montiel Quintero, Omar Kreidieh, Amitabh C Pandey, Han Feng, Qussay Marashly, Nassir F Marrouche

• July 20, 2026

Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function

• by Yaoting Wang, Lan Li, Liang Jin, Shikai Zhan, Hai Ren, Jiao Zhao, Qiuru Wang, Yiqiong Wang, Shudong Lin, Jiaxing Xin, Yao Dai, Yifan Zhou, Ting Zhang, Qian Liu, Yunyun Lu, Yiqi Zhu, Jiangyue Wu, Jiayan Lin, Shujing Zhang, Ling Zhang

• July 17, 2026

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.

• by Kathryn Wighton

• August 10, 2026

• 3 min